Bäst effekt om datorn får bestämma

Individanpassade läkemedel helt utvecklade i datorn, det är en verklighet som kan vara sann om tio år, tror Jens Nielsen, professor i systembiologi på Chalmers i Göteborg.

Vart tog ljuset i tunneln vägen?

Det är mycket svårt att utveckla läkemedel mot de stora volymsjukdomarna

EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Bio engineering breakthrough in Denmark

Brand new research makes BioGasol's cellulosic ethanol process even more competitive.

Hårdare krav på godkännanden i EU än i USA?

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

How to get the most out of the fair

LEO Pharma - International Clinical Trial Manager

A crash course in IP strategy

"Publish, publish, publish!" Sound familiar? So to meet the researcher's wishes, do you scribble a patent application with lipstick on a napkin and send it in? ...

High hopes for future partnering - the solution for struggling fairs

Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.

Ideon - Sweden's oldest science park

Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...